Peri‐implant diseases: Consensus Report of the Sixth European Workshop on Periodontology

Abstract

Issues related to peri‐implant disease were discussed. It was observed that the most common lesions that occur, i.e. peri‐implant mucositis and peri‐implantitis are caused by bacteria. While the lesion of peri‐implant mucositis resides in the soft tissues, peri‐implantitis also affects the supporting bone. Peri‐implant mucositis occurs in about 80% of subjects (50% of sites) restored with implants, and peri‐implantitis in between 28% and 56% of subjects (12–40% of sites). A number of risk indicators were identified including (i) poor oral hygiene, (ii) a history of periodontitis, (iii) diabetes and (iv) smoking. It was concluded that the treatment of peri‐implant disease must include anti‐infective measures. With respect to peri‐implant mucositis, it appeared that non‐surgical mechanical therapy caused the reduction in inflammation (bleeding on probing) but also that the adjunctive use of antimicrobial mouthrinses had a positive effect. It was agreed that the outcome of non‐surgical treatment of peri‐implantitis was unpredictable. The primary objective of surgical treatment in peri‐implantitis is to get access to the implant surface for debridement and decontamination in order to achieve resolution of the inflammatory lesion. There was limited evidence that such treatment with the adjunctive use of systemic antibiotics could resolve a number of peri‐implantitis lesions. There was no evidence that so‐called regenerative procedures had additional beneficial effects on treatment outcome.